GlyNAC

Updated June 3, 2026

GlyNAC is the informal name for a daily pairing of glycine and N-acetylcysteine, designed to refill the body's main intracellular antioxidant. That antioxidant is glutathione, and it does some of the most consequential work in the cell. It shields mitochondria from oxidative damage at the electron transport chain, where leaking electrons would otherwise generate superoxide and peroxynitrite. It feeds Phase II liver conjugation, where glutathione S-transferases tag fat-soluble toxins and drug metabolites for export. It recycles vitamin C back to its active form, which in turn recycles vitamin E, keeping the membrane antioxidant network running as a single circuit. It quietly keeps inflammation in check by limiting the oxidative signals that activate NF-kB. In healthy younger adults, the body makes plenty of glutathione on its own. In older adults, levels drop substantially, and a research program at Baylor College of Medicine has spent more than a decade showing that supplementing the two rate-limiting substrates brings glutathione back up to youthful levels and improves a long list of downstream markers.

The pairing's biochemistry is clean. Glutathione is built from three amino acids: glutamate, cysteine, and glycine. NAC has been used for decades to deliver cysteine, because cysteine has always been the assumed bottleneck. Sekhar's group looked again. Turns out older adults are also low in glycine, with lower plasma and intracellular pools than younger controls. Give only NAC and glutathione partially recovers. Add the glycine, and recovery goes further. Both rate-limiting steps unlock at once. Mitochondrial markers and oxidative-stress markers rise alongside the glutathione increase, exactly what you would predict if the mechanism is real. Glycine has its own quiet jobs too. It feeds the one-carbon cycle through serine hydroxymethyltransferase, supporting methylation and nucleotide synthesis. It is the backbone of collagen, occupying every third position in the triple helix.

The headline trial is from 2021 (Kumar et al., American Journal of Clinical Nutrition). Older adults took 100 mg/kg/day of each compound for twenty-four weeks, split across meals. Glutathione went up. Insulin sensitivity improved. Walking speed and grip strength improved. Several cognitive measures moved in the same direction. Oxidative-stress markers dropped. Sekhar's group also reported improvements in mitochondrial fatty-acid oxidation, lower inflammatory cytokines including IL-6 and TNF-alpha, reduced genomic damage markers, and better endothelial function. A smaller open-label study in HIV patients showed similar biomarker changes. The trial outcomes are concentrated in Sekhar's group, but they are consistent across multiple studies in different populations, and they all point the same way. This is one of the better-evidenced longevity-leaning combinations on the market.

Downstream matters. Restoring glutathione gives the cell better redox control, and several signaling levers move at once. NRF2 (the master regulator of antioxidant response) runs cleaner when glutathione is adequate. NF-kB (the central inflammatory transcription factor) activates less when ROS pressure drops. Mitochondrial membrane potential holds steadier. ATP synthesis stays efficient. Fewer leaky electrons mean less of the slow cellular wear that drives aging. Sekhar's papers frame the intervention against four hallmarks of aging at once: oxidative stress, mitochondrial dysfunction, inflammation, genomic instability.

Dosing is where users have a practical choice to make. The studied protocol uses 100 mg/kg/day of each, which works out to roughly seven or eight grams of glycine and the same of NAC for an average adult, split across two or three meals. That is the full trial-matched dose, and the literature supports it. Many users prefer a smaller real-world dose, around three grams of each per day in two doses, which is more comfortable to sustain over months. The lower dose has no direct trial evidence behind it. The biochemistry would predict proportionally smaller effects on glutathione levels, and that is the trade-off you accept for compliance.

Glycine is sweet, dissolves easily in water or juice, and tastes pleasant. NAC is bitter with a sulfurous edge that some people dislike, though most users settle into it. Mixing the two together with water and a splash of juice handles the taste well. Splitting the dose handles tolerability. With food or a small snack works for most people.

The most useful comparison is NAC alone versus GlyNAC. NAC by itself is cheaper, has its own established uses (lung mucus thinning, acute oxidative-stress contexts, established medical use in acetaminophen overdose), and is enough if those are your goals. Adding the glycine specifically addresses the dual-substrate deficiency Sekhar's group documented in older adults, and gives the body what it needs to synthesize glutathione at higher rates. A second comparison worth naming is liposomal glutathione, which delivers the finished molecule. It raises plasma glutathione, but the cell still resynthesizes for intracellular use, and trial evidence in older adults is thinner than the substrate approach. If the longevity-leaning glutathione angle is what brought you here, GlyNAC is the better-targeted choice.

A short note on regulation. NAC has had a strange history in the United States. The FDA has at points argued it should be regulated as a drug, because it was approved as one before it was sold as a supplement. It remains widely available. Outside the US, the supply picture is more straightforward.

A few real cautions. NAC at gram-level doses can cause nausea, headache, mild blood-pressure shifts, and occasional rashes. Splitting the dose and taking it with food handles most of these. People with cystinuria should not take NAC. People on nitrates need to clear it with a prescriber, because NAC can amplify nitrate-driven hypotension. People with kidney disease should not run the full studied dose without medical oversight given the substantial daily amino-acid load.

None of this is medical advice. If you take prescription medication, are pregnant, or have any chronic condition, talk to a clinician before adding GlyNAC.

What the protocol actually buys you. Higher intracellular glutathione. Better-running mitochondria, sharper insulin sensitivity, healthier vascular markers. Lower inflammatory tone through less NF-kB activation and reduced circulating IL-6 and TNF-alpha. A cleaner Phase II detox pipeline. Real functional gains in older adults in the published cohort. A clean way to support the body's primary antioxidant system across mitochondria, liver, and vasculature at once. Take the studied dose with clinician oversight if you want the trial-matched protocol. Use the lower exploratory dose if you want a sustainable daily routine. Either lands you on real biochemistry, doing real work.